Depletion of the cells expressing FAP-α enabled immune response-associated tumor regression, supporting the notion that FAP-α might act as an immune suppressor in pancreatic cancer (Kraman et al., 2010). The gene discussed is FAP; the disease is familial pancreatic carcinoma.